InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

UTAH MEDICAL PRODUCTS INC

UTMD Clue Score57
United States Fiscal year ends December CIK 0000706698
$74.54 +0.90% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $74.54 −17.39% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue39.3Operating income16.2Net income12.1EPS, diluted3.22Fiscal year 2017Revenue41.4 +5.4%Operating income19.0Net income8.5 −29.9%EPS, diluted2.28 −29.2%Fiscal year 2018Revenue42.0 +1.4%Operating income18.7Net income18.6 +118.2%EPS, diluted4.95 +117.1%Fiscal year 2019Revenue46.9 +11.7%Operating income17.6Net income14.7 −20.6%EPS, diluted3.94 −20.4%Fiscal year 2020Revenue42.2 −10.1%Operating income13.7Net income10.8 −26.7%EPS, diluted2.94 −25.4%Fiscal year 2021Revenue49.1 +16.3%Operating income18.9Net income14.8 +37.0%EPS, diluted4.04 +37.4%Fiscal year 2022Revenue52.3 +6.6%Operating income19.8Net income16.5 +11.4%EPS, diluted4.52 +11.9%Fiscal year 2023Revenue50.2 −3.9%Operating income16.8Net income16.6 +1.0%EPS, diluted4.57 +1.1%Fiscal year 2024Revenue40.9 −18.6%Operating income13.6Net income13.9 −16.6%EPS, diluted3.96 −13.3%Fiscal year 2025Revenue38.5 −5.8%Operating income11.4Net income11.3 −18.7%EPS, diluted3.48 −12.1%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 39.3 41.4 42.0 46.9 42.2 49.1 52.3 50.2 40.9 38.5
Growth +5.4% +1.4% +11.7% −10.1% +16.3% +6.6% −3.9% −18.6% −5.8%
Operating income 16.2 19.0 18.7 17.6 13.7 18.9 19.8 16.8 13.6 11.4
Net income 12.1 8.5 18.6 14.7 10.8 14.8 16.5 16.6 13.9 11.3
Growth −29.9% +118.2% −20.6% −26.7% +37.0% +11.4% +1.0% −16.6% −18.7%
EPS, diluted 3.22 2.28 4.95 3.94 2.94 4.04 4.52 4.57 3.96 3.48
Growth −29.2% +117.1% −20.4% −25.4% +37.4% +11.9% +1.1% −13.3% −12.1%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin60.3%Operating margin41.2%Net margin30.9%Free cash flow margin28.6%Fiscal year 2017Gross margin63.7%Operating margin45.9%Net margin20.5%Free cash flow margin37.0%Fiscal year 2018Gross margin62.6%Operating margin44.5%Net margin44.2%Free cash flow margin39.1%Fiscal year 2019Gross margin62.8%Operating margin37.6%Net margin31.4%Free cash flow margin35.2%Fiscal year 2020Gross margin60.6%Operating margin32.5%Net margin25.6%Free cash flow margin45.7%Fiscal year 2021Gross margin63.0%Operating margin38.5%Net margin30.1%Free cash flow margin42.1%Fiscal year 2022Gross margin61.6%Operating margin37.9%Net margin31.5%Free cash flow margin38.9%Fiscal year 2023Gross margin59.8%Operating margin33.4%Net margin33.1%Free cash flow margin43.1%Fiscal year 2024Gross margin59.0%Operating margin33.2%Net margin33.9%Free cash flow margin35.7%Fiscal year 2025Gross margin57.1%Operating margin29.6%Net margin29.3%Free cash flow margin37.2%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 60.3% 63.7% 62.6% 62.8% 60.6% 63.0% 61.6% 59.8% 59.0% 57.1%
Operating margin 41.2% 45.9% 44.5% 37.6% 32.5% 38.5% 37.9% 33.4% 33.2% 29.6%
Net margin 30.9% 20.5% 44.2% 31.4% 25.6% 30.1% 31.5% 33.1% 33.9% 29.3%
Free cash flow margin 28.6% 37.0% 39.1% 35.2% 45.7% 42.1% 38.9% 43.1% 35.7% 37.2%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow14.5Capital expenditure−3.3Free cash flow11.2Dividends paid−3.9Fiscal year 2017Operating cash flow16.9Capital expenditure−1.6Free cash flow15.3 +36.3%Buybacks0.0Dividends paid−3.0Fiscal year 2018Operating cash flow16.8Capital expenditure−0.4Free cash flow16.4 +7.3%Buybacks−1.2Dividends paid−4.0Fiscal year 2019Operating cash flow17.1Capital expenditure−0.5Free cash flow16.5 +0.5%Buybacks−0.4Dividends paid−4.1Fiscal year 2020Operating cash flow20.1Capital expenditure−0.9Free cash flow19.3 +16.7%Buybacks−7.0Dividends paid−4.1Fiscal year 2021Operating cash flow21.2Capital expenditure−0.6Free cash flow20.7 +7.1%Buybacks0.0Dividends paid−11.5Fiscal year 2022Operating cash flow21.1Capital expenditure−0.8Free cash flow20.3 −1.5%Buybacks−2.5Dividends paid−3.2Fiscal year 2023Operating cash flow22.3Capital expenditure−0.6Free cash flow21.6 +6.4%Buybacks0.0Dividends paid−4.3Fiscal year 2024Operating cash flow14.8Capital expenditure−0.2Free cash flow14.6 −32.5%Buybacks−20.0Dividends paid−4.3Fiscal year 2025Operating cash flow14.7Capital expenditure−0.4Free cash flow14.3 −1.9%Buybacks−8.4Dividends paid−4.0
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 14.5 16.9 16.8 17.1 20.1 21.2 21.1 22.3 14.8 14.7
Capital expenditure −3.3 −1.6 −0.4 −0.5 −0.9 −0.6 −0.8 −0.6 −0.2 −0.4
Free cash flow 11.2 15.3 16.4 16.5 19.3 20.7 20.3 21.6 14.6 14.3
Growth +36.3% +7.3% +0.5% +16.7% +7.1% −1.5% +6.4% −32.5% −1.9%
Buybacks n/a 0.0 −1.2 −0.4 −7.0 0.0 −2.5 0.0 −20.0 −8.4
Dividends paid −3.9 −3.0 −4.0 −4.1 −4.1 −11.5 −3.2 −4.3 −4.3 −4.0

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash26.3Shareholders’ equity69.2Fiscal year 2017Cash39.9Total debt0.0Net cash (debt)39.9Shareholders’ equity78.1Debt to equity0.00Fiscal year 2018Cash51.1Total debt0.0Net cash (debt)51.1Shareholders’ equity89.0Debt to equity0.00Fiscal year 2019Cash42.8Total debt0.0Net cash (debt)42.8Shareholders’ equity101.1Debt to equity0.00Fiscal year 2020Cash51.6Total debt0.0Net cash (debt)51.6Shareholders’ equity102.8Debt to equity0.00Fiscal year 2021Cash61.0Total debt0.0Net cash (debt)61.0Shareholders’ equity107.1Debt to equity0.00Fiscal year 2022Cash75.1Total debt0.0Net cash (debt)75.1Shareholders’ equity114.3Debt to equity0.00Fiscal year 2023Cash92.9Total debt0.0Net cash (debt)92.9Shareholders’ equity128.3Debt to equity0.00Fiscal year 2024Cash83.0Total debt0.0Net cash (debt)83.0Shareholders’ equity117.4Debt to equity0.00Fiscal year 2025Cash85.8Total debt0.0Net cash (debt)85.8Shareholders’ equity119.3Debt to equity0.00
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 26.3 39.9 51.1 42.8 51.6 61.0 75.1 92.9 83.0 85.8
Total debt n/a 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Net cash (debt) n/a 39.9 51.1 42.8 51.6 61.0 75.1 92.9 83.0 85.8
Shareholders’ equity 69.2 78.1 89.0 101.1 102.8 107.1 114.3 128.3 117.4 119.3
Debt to equity n/a 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
39.3 41.4 42.0 46.9 42.2 49.1 52.3 50.2 40.9 38.5
Growth +5.4% +1.4% +11.7% −10.1% +16.3% +6.6% −3.9% −18.6% −5.8%
15.6 15.0 15.7 17.4 16.6 18.1 20.1 20.2 16.8 16.5
23.7 26.4 26.3 29.5 25.5 30.9 32.2 30.0 24.1 22.0
Growth +11.4% −0.3% +12.0% −13.3% +21.0% +4.1% −6.7% −19.6% −8.9%
0.5 0.4 0.5 0.5 0.5 0.5 0.5 0.6 0.8 0.7
5.4 5.4 5.4 9.6 9.8 10.1 10.4 11.0 7.8 7.9
16.2 19.0 18.7 17.6 13.7 18.9 19.8 16.8 13.6 11.4
Growth +17.4% −1.7% −5.7% −22.3% +37.7% +4.8% −15.2% −19.0% −16.1%
16.4 19.1 19.5 17.9 13.8 19.1 20.7 20.1 16.8 14.1
4.3 10.6 0.9 3.2 3.0 4.3 4.2 3.5 2.9 2.8
12.1 8.5 18.6 14.7 10.8 14.8 16.5 16.6 13.9 11.3
Growth −29.9% +118.2% −20.6% −26.7% +37.0% +11.4% +1.0% −16.6% −18.7%
Per share
3.23 2.29 4.97 3.96 2.95 4.05 4.53 4.58 3.96 3.48
3.22 2.28 4.95 3.94 2.94 4.04 4.52 4.57 3.96 3.48
Growth −29.2% +117.1% −20.4% −25.4% +37.4% +11.9% +1.1% −13.3% −12.1%
3.8 3.7 3.7 3.7 3.7 3.6 3.6 3.6 3.5 3.2
3.8 3.7 3.7 3.7 3.7 3.7 3.6 3.6 3.5 3.2
Growth −0.8% +0.3% −0.2% −1.8% −0.3% −0.5% −0.2% −3.7% −7.5%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 1.8% a year over five years, and earnings per share grew 3.4% a year.
  • The diluted share count fell 11.8% in five years, so buybacks did some of the work per share.
  • Operating margin is down 2.9 points on five years ago, at 29.6%.
  • Profitable in every one of the 10 years on file.